Concord Biotech Share Price Today - Live Research Rating for Concord Biotech on Equentis

Home

Stocks Screener

Concord Biotech Share Price

Concord Biotech (INR)185022.3 (1.2%)

Exchange ScripsBSE543960NSECONCORDBIOISININE338H01029

Stock Performance

Fundamentals

Technicals

Shareholding Patterns

Financials

Similar Stocks

Trendline of performance -

Concord Biotech Performance

Market performance

Open price1827.7

High1867.1

Volumes43172

Prev Close1850

Low1804.5

Closing date2024-11-08

Historical performance

1 Year High2664.00

3 Year High2664.00

5 Year High2664.00

1 Year Low1205.45

3 Year Low900.05

5 Year Low900.05

Concord Biotech Fundamentals

Company Valuation

Market Cap (₹Cr)

19406

Face Value (₹)

P/E Ratio

62.82

Dividend Yield

0.47 %

Concord Biotech Investment Returns

1 Year

39.7%

3 Years

N/A

5 Years

N/A

10 Years

N/A

Concord Biotech Technicals

Indicators	Value	Signal
5-DMA	1828.41	Bullish
10-DMA	1828.9	Bullish
20-DMA	1872.05	Bearish
50-DMA	1947.75	Bearish
100-DMA	1784.9	Bullish
200-DMA	1634.25	Bullish

Shareholding Pattern

Field	Sep-2024	Jun-2024	Mar-2024	Dec-2023	Sep-2023
Promoters	6	6	6	6	6
Foreign Investors	---	---	---	---	---
Domestic Investors	6	6	6	6	6
Public Investors	84292	80731	83290	87480	100921
Government	---	---	---	---	---

Concord Biotech Financials

Below figures are in Rs. Crores

Particulars	Mar-2024	Mar-2023	Mar-2022	Mar-2021
Other Income	338	353	234	138
Operating Profit	4660	3839	2973	3417
Interest	32	98	61	10
Depreciation	536	540	500	275
Profit Before Tax	4126	3220	2375	3127
Consolidated Net Profit	3081	2401	1749	2348
Adjusted EPS	29	23	17	22

Balance Sheet

Below figures are in Rs. Crores

Particulars	Mar-2024	Mar-2023	Mar-2022	Mar-2021
Share Capital	105	105	95	95
Total Reserves	15162	12795	10937	9899
Minority Interest	---	---	---	---
Total Non-Current Liabilities	319	321	544	774
Total Liabilities	17007	15140	15019	13127
Capital Work in Progress	2115	1727	742	179
Total Assets	17007	15140	15019	13127

Cash Flow

Below figures are in Rs. Crores

Particulars	Mar-2024	Mar-2023	Mar-2022	Mar-2021
Cash Flow from Operating Activities	2655	2460	2075	1668
Cash Flow from Investing Activities	-1546	-1580	-1118	-1952
Cash Flow from Financing Activitie	-992	-852	-1002	311
Net Cash Inflow / Outflow	116	28	-45	27

Negative

Neutral

Positive

The stock has a PE ratio of 62.82.
3Y Stock Price CAGR of the stock is 96.2.
The stock has a beta of 0.6.
In the last financial year, the company had an EBITDA of ₹4660 Million.
The company generated revenue of ₹10169 Million in the previous financial year.

Concord Biotech

185022.3 (1.2%)

Investment Amount: ₹ 133070

Current Value: ₹ 185000

Performence: 39%

P/L: ₹ 51930

Top Gainers

Symbol	Change%
VIMTALABS	694.05(20%)
HERCULES	286.9(20%)
JSWHL	15434.8(18%)
TERASOFT	116.58(14%)
ITI	304.24(14%)

Top Losers

Symbol	Change%
BBL	4011.15(-16%)
MATRIMONY	734.1(-11%)
ELECTCAST	151.12(-10%)
SIGNATURE	1268.5(-8%)
IFCI	61.59(-8%)
AARTIIND	474.4(-8%)
DYCL	829.9(-8%)
ORIENTBELL	313.9(-8%)

Similar stocks

Jagsonpal Pharma

▲ 43.2

591.5

October 10 - November 10

Unichem Lab

▲ 39.5

899.65

October 10 - November 10

Vimta Labs

▲ 29.8

694.05

October 10 - November 10

Innova Captab

▲ 29.3

951.55

October 10 - November 10

Wockhardt

▲ 29.2

1236.3

October 10 - November 10

Panacea Biotec

▲ 28.9

357.5

October 10 - November 10

Gufic Biosciences

▲ 25.9

485.45

October 10 - November 10

Piramal Pharma

▲ 25.6

281.55

October 10 - November 10

Announcing Stock of the Month!

Concord Biotech Share PricePharmaceuticals & Drugs

Trendline of performance -

Concord Biotech Performance

Market performance

Historical performance

Concord Biotech Fundamentals

Company Valuation

Concord Biotech Investment Returns

Concord Biotech Technicals

Shareholding Pattern

Concord Biotech Financials

Balance Sheet

Cash Flow

Top Gainers

Top Losers

Similar stocks

Concord Biotech Share Price